Ge Healthcare Technologies Stock Performance
| GEHC Stock | 82.00 2.90 3.42% |
The company owns a Beta (Systematic Risk) of 0.23, which attests to not very significant fluctuations relative to the market. As returns on the market increase, GE HealthCare's returns are expected to increase less than the market. However, during the bear market, the loss of holding GE HealthCare is expected to be smaller as well. At this point, GE HealthCare Techno has a negative expected return of -0.0377%. Please make sure to check out GE HealthCare's sortino ratio, semi variance, and the relationship between the information ratio and value at risk , to decide if GE HealthCare Techno performance from the past will be repeated sooner or later.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days GE HealthCare Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical indicators, GE HealthCare is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Actual Historical Performance (%)
One Day Return (3.16) | Five Day Return (0.71) | Year To Date Return 7.66 | Ten Year Return 37.03 | All Time Return 37.03 |
Forward Dividend Yield 0.0014 | Payout Ratio 0.0284 | Forward Dividend Rate 0.12 | Dividend Date 2024-11-15 | Ex Dividend Date 2024-10-18 |
1 | Bar Harbor Wealth Management Trims Holdings in GE HealthCare Technologies Inc. | 10/18/2024 |
2 | GE HealthCare Technologies Inc. is favoured by institutional owners who hold 77 percent of the company | 10/28/2024 |
3 | GE HealthCare Technologies Inc. Q3 2024 Earnings Call Transcript | 11/01/2024 |
4 | Disposition of 3577 shares by Roland Rott of GE HealthCare at 86.48 subject to Rule 16b-3 | 11/04/2024 |
5 | GE Healthcare commences secondary offering of 13.3M shares | 11/07/2024 |
6 | GE HealthCare Technologies prices 13M share secondary offering | 11/08/2024 |
7 | GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence with SmartTechnology | 11/11/2024 |
8 | GE HealthCare Announces Initiative to Help Address Radiologic Technologist Shortage | 11/12/2024 |
9 | GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System | 11/13/2024 |
| GE HealthCare dividend paid on 15th of November 2024 | 11/15/2024 |
11 | Disposition of 4292 shares by Jan Makela of GE HealthCare at 91.28 subject to Rule 16b-3 | 11/18/2024 |
12 | Grandfield Dodd LLC Purchases 2,101 Shares of GE HealthCare Technologies Inc. | 11/20/2024 |
| Begin Period Cash Flow | 1.5 B |
GEHC |
GE HealthCare Relative Risk vs. Return Landscape
If you would invest 8,446 in GE HealthCare Technologies on August 24, 2024 and sell it today you would lose (246.00) from holding GE HealthCare Technologies or give up 2.91% of portfolio value over 90 days. GE HealthCare Technologies is currently does not generate positive expected returns and assumes 1.3709% risk (volatility on return distribution) over the 90 days horizon. In different words, 12% of stocks are less volatile than GEHC, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
GE HealthCare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for GE HealthCare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as GE HealthCare Technologies, and traders can use it to determine the average amount a GE HealthCare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0275
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GEHC |
Estimated Market Risk
| 1.37 actual daily | 12 88% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average GE HealthCare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GE HealthCare by adding GE HealthCare to a well-diversified portfolio.
GE HealthCare Fundamentals Growth
GEHC Stock prices reflect investors' perceptions of the future prospects and financial health of GE HealthCare, and GE HealthCare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on GEHC Stock performance.
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.0564 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 45.97 B | ||||
| Shares Outstanding | 456.87 M | ||||
| Price To Book | 4.66 X | ||||
| Price To Sales | 1.98 X | ||||
| Revenue | 19.55 B | ||||
| Gross Profit | 7.18 B | ||||
| EBITDA | 2.44 B | ||||
| Net Income | 1.57 B | ||||
| Total Debt | 9.86 B | ||||
| Book Value Per Share | 18.20 X | ||||
| Cash Flow From Operations | 2.1 B | ||||
| Earnings Per Share | 3.65 X | ||||
| Market Capitalization | 38.79 B | ||||
| Total Asset | 32.45 B | ||||
| Retained Earnings | 1.33 B | ||||
| Working Capital | 429 M | ||||
About GE HealthCare Performance
By analyzing GE HealthCare's fundamental ratios, stakeholders can gain valuable insights into GE HealthCare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if GE HealthCare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if GE HealthCare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 61.51 | 51.23 | |
| Return On Tangible Assets | 0.09 | 0.17 | |
| Return On Capital Employed | 0.10 | 0.14 | |
| Return On Assets | 0.05 | 0.08 | |
| Return On Equity | 0.22 | 0.14 |
Things to note about GE HealthCare Techno performance evaluation
Checking the ongoing alerts about GE HealthCare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for GE HealthCare Techno help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| GE HealthCare Techno generated a negative expected return over the last 90 days | |
| Over 84.0% of the company shares are owned by institutional investors | |
| On 15th of November 2024 GE HealthCare paid 0.03 per share dividend to its current shareholders | |
| Latest headline from thelincolnianonline.com: Grandfield Dodd LLC Purchases 2,101 Shares of GE HealthCare Technologies Inc. |
- Analyzing GE HealthCare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether GE HealthCare's stock is overvalued or undervalued compared to its peers.
- Examining GE HealthCare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating GE HealthCare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of GE HealthCare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of GE HealthCare's stock. These opinions can provide insight into GE HealthCare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for GEHC Stock analysis
When running GE HealthCare's price analysis, check to measure GE HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GE HealthCare is operating at the current time. Most of GE HealthCare's value examination focuses on studying past and present price action to predict the probability of GE HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GE HealthCare's price. Additionally, you may evaluate how the addition of GE HealthCare to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |